Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized ...

Among the most promising treatment strategies to emerge in recent times is CAR-T cell therapy, which involves reprogramming a patient's immune cells to recognize, target and kill cancer cells.

Breakthrough nanovaccine uses tumor cell membranes and immune-boosting polymers to enhance personalized cancer immunotherapy, ...

Scientists with the Fralin Biomedical Research Institute at VTC have created an engineered model of the supportive tissue ...

Virginia Tech researchers have created an engineered model of the supportive tissue found within a lymph node to study human ...

Weizmann scientists uncover why our immune system lets us eat without harm, how it tolerates food—and why it sometimes fails.

Inflammation and tumorigenesis are intricately connected processes with significant overlap in their underlying mechanisms. Chronic inflammation is now ...

Among the most promising treatment strategies to emerge in recent times is CAR-T cell therapy, which involves reprogramming a patient's immune cells to recognise, target and kill cancer cells.

The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, ...

B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based ...